Sanjivani Paranteral MD, chairman, board of directors and AGM
BSE: 531569Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹160.40.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹188 Cr2,377th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 3.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 20.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 0.28
- Volume, BSEVolume. Shares traded on the last trading day.
- 12,429
Sanjivani Paranteral board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorASHWANI ANAMISHARAN KHEMKA
- Company Secretary and Compliance OfficerRavikumar Bogam
5 directors3 independent2 executive
- ASHWANI ANAMISHARAN KHEMKA · Chairperson and managing directorExecutive · joined Oct 1994 · 381 months as independent · 1 listed board
- SRIVARDHAN ASHWANI KHEMKAExecutive · joined Mar 2022 · 51 months as independent · 1 listed board · 2 committee seats
- MONIKA AMIT SINGHANIAIndependent · joined Mar 2022 · 51 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 1 as chair
- ABHAY MILAN SHAHIndependent · joined Apr 2024 · 27 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
- BASANT SHRIVASTAVAIndependent · joined Sep 2025 · 10 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- MRUNMAI MAHENDRA SARVANKAR, left 19 Sep 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 21 May 20265 of 5 present3 independent · 6 days in between
- 14 May 20265 of 5 present3 independent · 89 days in between
- 13 Feb 20265 of 5 present3 independent
Audit Committee
Chair ABHAY MILAN SHAH
MONIKA AMIT SINGHANIA, SRIVARDHAN ASHWANI KHEMKA
- 21 May 20263 of 3 present2 independent · 6 days in between
- 14 May 20263 of 3 present2 independent · 89 days in between
- 13 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair BASANT SHRIVASTAVA
MONIKA AMIT SINGHANIA, ABHAY MILAN SHAH
- 14 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair MONIKA AMIT SINGHANIA
SRIVARDHAN ASHWANI KHEMKA, BASANT SHRIVASTAVA
- 13 Feb 20263 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M/s R B GOHIL & COPeer-review certificate valid to Dec 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Sanjivani Paranteral AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Sanjivani Paranteral dividend history
Annual general meeting, 16 Sep 2026
5,901 shareholders on the register on 9 Sep 2026; present: 1 promoter and 37 others; votes counted by Hardik Darji / HD and Associates.The company's voting result (opens in a new tab)
- To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026 together with the reports of Board of Directors and Auditors thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 51.51% · promoters 100.00% · institutions 0.00% · other public 31.39%
- To appoint Mr. Ashwani Khemka (DIN: 00337118), who retires by rotation at this annual general meeting and being eligible, offers himself for re-appointmentOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 19.94% · promoters 0.00% · institutions 0.00% · other public 31.39%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 22 Aug 2026, 2 resolutions
5,143 shareholders on the register on 17 Mar 2026; votes counted by HARDIK DARJI / HD AND ASSOCIATES.The company's voting result (opens in a new tab)
- ISSUANCE OF UPTO 5,00,000 (FIVE LAKH) CONVERTIBLE WARRANTS TO THE ENTITY BELONGING TO THE 'PROMOTER & PROMOTER GROUP' ON PREFERENTIAL BASISSpecialPromoters have an interest in it99.91% for0.09% against
Against: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 18.63% · promoters 0.00% · institutions 0.00% · other public 29.36%
- TO CONSIDER AND APPROVE MATERIAL RELATED PARTY TRANSACTIONS UNDER REGULATION 23 OF SEBI (LODR) REGULATION, 2015 BETWEEN THE COMPANY AND SPL INFUSION PRIVATE LIMITED (A SUBSIDIARY OF THE COMPANY)OrdinaryPromoters have an interest in it99.91% for0.09% against
Against: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 18.63% · promoters 0.00% · institutions 0.00% · other public 29.36%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Sep 2025. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A statement's amounts are left out where the raise it states is more than ten times everything the company owns, a figure typed at the wrong scale.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| OthersJan 2024 | – | The Company intends to raise funds for its future expansion and growth of the Company, through Issuance of Convertible Warrants. | – | – | No |